Skip to main content
. Author manuscript; available in PMC: 2016 Feb 20.
Published in final edited form as: AIDS. 2015 Feb 20;29(4):443–452. doi: 10.1097/QAD.0000000000000565

Table 2.

Dietary and Serum Choline-Related Metabolites among Controls and HIV-Infected Subjects

Control Subjects (n=67) HIV-Infected Subjects (n=155) P-value
Dietary Intake
 Betaine, mg 155.9 (90.3–208.9) 128.9 (94.2–182.3) 0.43
 Choline, mg 349.2 (251.5–464.8) 330.7 (218.9–429.4) 0.60
Serum Metabolites
 Betaine, μmol/L 6.1 (4.7–7.7) 5.8 (5.1–7.0) 0.32
 L-Carnitine, μmol/L 5.9 (4.9–6.7) 5.8 (4.5–6.9) 0.58
 Choline, μmol/L 2.0 (1.8–2.2) 1.9 (1.7–2.3) 0.88
 TMA, μmol/L 0.3 (0.3–0.4) 0.3 (0.3–1.5) 0.50
 TMAO, μmol/L 0.7 (0.5–1.0) 0.7 (0.5–1.1) 0.79

Data reported as median (interquartile range). Abbreviations: TMA, trimethylamine; TMAO, trimethylamine-N-oxide.

Food record data were available for 36 control subjects and 100 HIV-infected subjects.

HHS Vulnerability Disclosure